-+ 0.00%
-+ 0.00%
-+ 0.00%

Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky sells 1,195 shares for $32,265

PUBT·09/17/2026 22:51:02
Listen to the news
Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky sells 1,195 shares for $32,265
  • Adaptive Biotechnologies Chief Commercial Officer, MRD Susan Bobulsky sold 1,195 common shares on Sep. 15, 2026 at USD 27.
  • Direct holdings roseported at 395,794 shares following the transaction.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adaptive Biotechnologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001820885-26-000023), on September 17, 2026, and is solely responsible for the information contained therein.